Skip to content

Supplier News

Hyland’s expands commitment to sport cycling

Hyland’s expands commitment to sport cycling

LOS ANGELES – Homeopathic medicine supplier Hyland’s Inc. is continuing its advertorial relationship with NBC and the Tour de France in 2018. The partnership allows Hyland’s to leverage NBC’s extensive network to connect with cyclists on the world’s biggest stage.

New Voices Fund rolls out during 2018 Essence Festival

New Voices Fund rolls out during 2018 Essence Festival

NEW YORK – The $100 million New Voices Fund, the next-generation fund set up to make private equity investments in businesses owned and/or managed by women of color, officially launched today at the 2018 Essence Festival in New Orleans.

Catalent agrees to buy Juniper Pharmaceuticals

Catalent agrees to buy Juniper Pharmaceuticals

SOMERSET, N.J. – Catalent, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,  announced that it has agreed to acquire Juniper Pharmaceuticals, including its Nottingham, U.K.-based Juniper Pharma Services division.

FDA approves Xeomin for adult patients with sialorrhea

FDA approves Xeomin for adult patients with sialorrhea

Merz North America announced  that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, in adult patients.

Eos Products hires Kang as new CMO

Eos Products hires Kang as new CMO

Eos Products, known for its iconic lip balms, shave creams, and hand & body lotions, has appointed of Soyoung Kang as chief marketing officer. In her new role, Kang is responsible for global brand strategy, communications, and innovation.

Dermira gets FDA approval for Qbrexza cloth

Dermira gets FDA approval for Qbrexza cloth

Dermira announced that the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

Novartis seeks approval to spinoff Alcon eye care biz

Novartis seeks approval to spinoff Alcon eye care biz

Novartis today announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies.

gel-e expands its OTC label

gel-e expands its OTC label

gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (O-T-C) use of its first flowable hemostat.